A multicenter, open-label, phase 2 study of Imprime PGG and pembrolizumab in patients with metastatic breast cancer who have progressed through prior hormonal therapyAlison Stopeck, Michele Gargano,Nandita Bose,Nick Niles,Michael Chisamore,Jose IglesiasCANCER RESEARCH（2022）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
